FibroBiologics FBLG
NASDAQ FBLG
$1.10 +0.10 (+10.10%)
As of: Oct 22, 2026 · 10:25 AM EDT

FibroBiologics (FBLG) Convertible Debt (2022)

Updated

FibroBiologics (FBLG) reported Convertible Debt of $5.6 million for Q4 2022.

Analysis

FibroBiologics (FBLG) Convertible Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn
10 FibroBiologics 6.84 Mn -7.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 5.60 Mn
API Access

FibroBiologics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=FBLG&period=max&api_key=YOUR_API_KEY